Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-05-05 Purchase | 2022-05-09 09:32 am | Sage Therapeutics Inc. | SAGE | Golumbeski George Director | 8,000 | $31.45 | $251,563 | 8,000 (Direct) | View |
| 2021-08-05 Purchase | 2021-08-09 09:07 am | Sage Therapeutics Inc. | SAGE | Greene Barry E CEO | 23,640 | $43.15 | $1,020,054 | 32,440 (Direct) | View |
| 2021-06-16 Purchase | 2021-06-17 4:04 pm | Sage Therapeutics Inc. | SAGE | FRATES JAMES M Director | 1,810 | $55.1 | $99,735 | 2,845 (Indirect Direct) | View |
| 2021-06-16 Purchase | 2021-06-17 09:15 am | Sage Therapeutics Inc. | SAGE | STARR KEVIN P Director | 17,842 | $56.05 | $999,983 | 320,659 (Direct) | View |
| 2021-06-16 Purchase | 2021-06-17 09:14 am | Sage Therapeutics Inc. | SAGE | Greene Barry E CEO | 8,800 | $56.32 | $495,627 | 8,800 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-16 Option Award | 2022-06-21 4:02 pm | N/A 2032-06-16 | Sage Therapeutics Inc. | SAGE | Benecchi Christopher Chief Commercial Officer | 9,500 | $0 | 9,500 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-17 4:36 pm | N/A 2032-06-16 | Sage Therapeutics Inc. | SAGE | FRATES JAMES M Director | 9,947 | $0 | 9,947 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-17 4:36 pm | N/A 2032-06-16 | Sage Therapeutics Inc. | SAGE | COLA MICHAEL F Director | 9,947 | $0 | 9,947 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-17 4:35 pm | N/A 2032-06-16 | Sage Therapeutics Inc. | SAGE | Golumbeski George Director | 9,947 | $0 | 9,947 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-17 4:35 pm | N/A 2032-06-16 | Sage Therapeutics Inc. | SAGE | Barrett Elizabeth Director | 9,947 | $0 | 9,947 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-17 4:35 pm | N/A 2032-06-16 | Sage Therapeutics Inc. | SAGE | Germano Geno J Director | 9,947 | $0 | 9,947 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-17 4:35 pm | N/A 2032-06-16 | Sage Therapeutics Inc. | SAGE | PAUL STEVEN M Director | 9,947 | $0 | 9,947 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-17 4:35 pm | N/A 2032-06-16 | Sage Therapeutics Inc. | SAGE | STARR KEVIN P Director | 9,947 | $0 | 9,947 (Direct) | View |
| 2022-04-27 Exercise | 2022-04-29 08:40 am | N/A 2023-08-12 | Sage Therapeutics Inc. | SAGE | JONAS JEFFREY M Director | 30,944 | $0 | 127,450 (Direct) | View |
| 2022-04-27 Exercise | 2022-04-29 08:40 am | N/A N/A | Sage Therapeutics Inc. | SAGE | JONAS JEFFREY M Director | 30,944 | $0.45 | 127,450 (Direct) | View |
| 2022-02-17 Exercise | 2022-02-18 4:10 pm | N/A 2024-01-22 | Sage Therapeutics Inc. | SAGE | IGUCHI KIMI CFO | 4,500 | $0 | 64,642 (Direct) | View |
| 2022-02-17 Exercise | 2022-02-18 4:10 pm | N/A N/A | Sage Therapeutics Inc. | SAGE | IGUCHI KIMI CFO | 4,500 | $1.36 | 64,642 (Direct) | View |
| 2022-02-17 Exercise | 2022-02-18 4:10 pm | N/A 2023-08-12 | Sage Therapeutics Inc. | SAGE | JONAS JEFFREY M Chief Innovation Officer | 4,000 | $0 | 127,450 (Direct) | View |
| 2022-02-17 Exercise | 2022-02-18 4:10 pm | N/A N/A | Sage Therapeutics Inc. | SAGE | JONAS JEFFREY M Chief Innovation Officer | 4,000 | $0.45 | 127,450 (Direct) | View |
| 2022-02-11 Option Award | 2022-02-15 4:43 pm | N/A 2032-02-11 | Sage Therapeutics Inc. | SAGE | Benecchi Christopher Chief Commercial Officer | 11,400 | $0 | 11,400 (Direct) | View |
| 2022-02-11 Option Award | 2022-02-15 4:42 pm | N/A 2032-02-11 | Sage Therapeutics Inc. | SAGE | Greene Barry E CEO | 69,920 | $0 | 69,920 (Direct) | View |
| 2022-02-11 Option Award | 2022-02-15 4:42 pm | N/A 2032-02-11 | Sage Therapeutics Inc. | SAGE | Robichaud Albert Chief Scientific Officer | 13,300 | $0 | 13,300 (Direct) | View |
| 2022-02-11 Option Award | 2022-02-15 4:42 pm | N/A 2032-02-11 | Sage Therapeutics Inc. | SAGE | IGUCHI KIMI CFO | 15,200 | $0 | 15,200 (Direct) | View |
| 2022-02-11 Option Award | 2022-02-15 4:41 pm | N/A 2032-02-11 | Sage Therapeutics Inc. | SAGE | Cook Anne Marie VP | 15,200 | $0 | 15,200 (Direct) | View |
| 2022-02-11 Option Award | 2022-02-15 4:41 pm | N/A 2032-02-11 | Sage Therapeutics Inc. | SAGE | JONAS JEFFREY M Chief Innovation Officer | 15,200 | $0 | 15,200 (Direct) | View |
| 2022-01-04 Option Award | 2022-01-05 4:08 pm | N/A 2032-01-04 | Sage Therapeutics Inc. | SAGE | PAUL STEVEN M Director | 1,638 | $0 | 1,638 (Direct) | View |
| 2022-01-04 Option Award | 2022-01-05 4:08 pm | N/A 2032-01-04 | Sage Therapeutics Inc. | SAGE | Barrett Elizabeth Director | 2,048 | $0 | 2,048 (Direct) | View |
| 2022-01-04 Option Award | 2022-01-05 4:08 pm | N/A 2032-01-04 | Sage Therapeutics Inc. | SAGE | Golumbeski George Director | 1,638 | $0 | 1,638 (Direct) | View |
| 2021-11-22 Exercise | 2021-11-23 5:15 pm | N/A 2024-01-22 | Sage Therapeutics Inc. | SAGE | IGUCHI KIMI CFO | 3,500 | $0 | 65,137 (Direct) | View |
| 2021-11-22 Exercise | 2021-11-23 5:15 pm | N/A N/A | Sage Therapeutics Inc. | SAGE | IGUCHI KIMI CFO | 3,500 | $1.36 | 65,137 (Direct) | View |
| 2021-11-09 Other | 2021-11-12 4:53 pm | N/A N/A | Sage Therapeutics Inc. | SAGE | PAUL STEVEN M Director | 1 | $43.36 | 514,573 (Indirect) | View |
| 2021-10-19 Option Award | 2021-10-21 4:04 pm | N/A N/A | Sage Therapeutics Inc. | SAGE | IGUCHI KIMI CFO | 3,800 | $0 | 47,600 (Direct) | View |
| 2021-10-19 Tax Withholding | 2021-10-21 4:04 pm | N/A N/A | Sage Therapeutics Inc. | SAGE | IGUCHI KIMI CFO | 1,024 | $40.29 | 47,600 (Direct) | View |
| 2021-10-19 Option Award | 2021-10-21 4:03 pm | N/A N/A | Sage Therapeutics Inc. | SAGE | Robichaud Albert Chief Scientific Officer | 3,800 | $0 | 142,619 (Direct) | View |
| 2021-10-19 Tax Withholding | 2021-10-21 4:03 pm | N/A N/A | Sage Therapeutics Inc. | SAGE | Robichaud Albert Chief Scientific Officer | 1,116 | $40.29 | 142,619 (Direct) | View |
| 2021-10-19 Option Award | 2021-10-21 4:03 pm | N/A N/A | Sage Therapeutics Inc. | SAGE | Cook Anne Marie VP | 3,800 | $0 | 7,894 (Direct) | View |
| 2021-10-19 Tax Withholding | 2021-10-21 4:03 pm | N/A N/A | Sage Therapeutics Inc. | SAGE | Cook Anne Marie VP | 1,116 | $40.29 | 7,894 (Direct) | View |
| 2021-10-19 Option Award | 2021-10-21 4:03 pm | N/A N/A | Sage Therapeutics Inc. | SAGE | JONAS JEFFREY M Chief Innovation Officer | 10,000 | $0 | 80,863 (Direct) | View |
| 2021-10-19 Tax Withholding | 2021-10-21 4:03 pm | N/A N/A | Sage Therapeutics Inc. | SAGE | JONAS JEFFREY M Chief Innovation Officer | 4,374 | $40.29 | 80,863 (Direct) | View |
| 2021-10-19 Option Award | 2021-10-21 4:02 pm | N/A N/A | Sage Therapeutics Inc. | SAGE | Kanes Stephen Chief Medical Officer | 3,800 | $0 | 13,471 (Direct) | View |
| 2021-10-19 Tax Withholding | 2021-10-21 4:02 pm | N/A N/A | Sage Therapeutics Inc. | SAGE | Kanes Stephen Chief Medical Officer | 1,120 | $40.29 | 13,471 (Direct) | View |
| 2021-10-01 Option Award | 2021-10-04 4:10 pm | N/A 2031-10-01 | Sage Therapeutics Inc. | SAGE | Benecchi Christopher Chief Commercial Officer | 45,000 | $0 | 45,000 (Direct) | View |
| 2021-06-15 Option Award | 2021-06-17 09:14 am | N/A N/A | Sage Therapeutics Inc. | SAGE | Cook Anne Marie VP | 4,000 | $0 | 4,973 (Direct) | View |
| 2021-06-15 Tax Withholding | 2021-06-17 09:14 am | N/A N/A | Sage Therapeutics Inc. | SAGE | Cook Anne Marie VP | 1,144 | $58.8 | 4,973 (Direct) | View |
| 2021-06-15 Exercise | 2021-06-17 09:13 am | N/A 2023-08-12 | Sage Therapeutics Inc. | SAGE | JONAS JEFFREY M Chief Innovation Officer | 12,000 | $0 | 121,824 (Direct) | View |
| 2021-06-15 Exercise | 2021-06-17 09:13 am | N/A N/A | Sage Therapeutics Inc. | SAGE | JONAS JEFFREY M Chief Innovation Officer | 12,000 | $0.45 | 121,824 (Direct) | View |
| 2021-06-15 Option Award | 2021-06-17 09:13 am | N/A N/A | Sage Therapeutics Inc. | SAGE | JONAS JEFFREY M Chief Innovation Officer | 10,000 | $0 | 121,824 (Direct) | View |
| 2021-06-15 Tax Withholding | 2021-06-17 09:13 am | N/A N/A | Sage Therapeutics Inc. | SAGE | JONAS JEFFREY M Chief Innovation Officer | 3,093 | $58.8 | 121,824 (Direct) | View |
| 2021-06-15 Option Award | 2021-06-17 09:12 am | N/A N/A | Sage Therapeutics Inc. | SAGE | Robichaud Albert Chief Scientific Officer | 4,000 | $0 | 139,651 (Direct) | View |
| 2021-06-15 Tax Withholding | 2021-06-17 09:12 am | N/A N/A | Sage Therapeutics Inc. | SAGE | Robichaud Albert Chief Scientific Officer | 1,144 | $58.8 | 139,651 (Direct) | View |
| 2021-06-15 Option Award | 2021-06-17 09:12 am | N/A N/A | Sage Therapeutics Inc. | SAGE | Kanes Stephen Chief Medical Officer | 3,500 | $0 | 10,791 (Direct) | View |
| 2021-06-15 Tax Withholding | 2021-06-17 09:12 am | N/A N/A | Sage Therapeutics Inc. | SAGE | Kanes Stephen Chief Medical Officer | 1,001 | $58.8 | 10,791 (Direct) | View |
| 2021-06-15 Exercise | 2021-06-17 09:12 am | N/A 2024-01-22 | Sage Therapeutics Inc. | SAGE | IGUCHI KIMI CFO | 5,000 | $0 | 74,627 (Direct) | View |
| 2021-06-15 Option Award | 2021-06-17 09:12 am | N/A N/A | Sage Therapeutics Inc. | SAGE | IGUCHI KIMI CFO | 3,500 | $0 | 74,627 (Direct) | View |
| 2021-06-15 Exercise | 2021-06-17 09:12 am | N/A N/A | Sage Therapeutics Inc. | SAGE | IGUCHI KIMI CFO | 5,000 | $1.36 | 74,627 (Direct) | View |
| 2021-06-15 Tax Withholding | 2021-06-17 09:12 am | N/A N/A | Sage Therapeutics Inc. | SAGE | IGUCHI KIMI CFO | 822 | $58.8 | 74,627 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-11 4:11 pm | N/A 2031-06-10 | Sage Therapeutics Inc. | SAGE | FRATES JAMES M Director | 10,000 | $0 | 10,000 (Direct) | View |